HETEROCYCLIC INHIBITORS OF HISTAMINE RECEPTORS FOR THE TREATMENT OF DISEASE
申请人:Borchardt Allen
公开号:US20110237565A1
公开(公告)日:2011-09-29
The present invention relates to compounds and methods which may be useful as inhibitors of H
4
R for the treatment or prevention of inflammatory, autoimmune, allergic, and ocular diseases.
TETRAZOLO[1,5-a]PYRAZINE COMPOUNDS AS INHIBITORS OF HISTAMINE RECEPTORS
申请人:Kalypsys, Inc.
公开号:EP2545058B1
公开(公告)日:2016-08-24
US8569300B2
申请人:——
公开号:US8569300B2
公开(公告)日:2013-10-29
[EN] HETEROCYCLIC INHIBITORS OF HISTAMINE RECEPTORS FOR THE TREATMENT OF DISEASE<br/>[FR] INHIBITEURS HÉTÉROCYCLIQUES DE RÉCEPTEURS DE L'HISTAMINE DESTINÉS AU TRAITEMENT DE MALADIE
申请人:KALYPSYS INC
公开号:WO2011112766A2
公开(公告)日:2011-09-15
The present invention relates to compounds and methods which may be useful as inhibitors of H4R for the treatment or prevention of inflammatory, autoimmune, allergic, and ocular diseases.